Tema Oncology ETF (NASDAQ:CANC) Sees Significant Increase in Short Interest

Posted by Anthony Bellafiore on Feb 3rd, 2025

Tema Oncology ETF (NASDAQ:CANC – Get Free Report) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 7,400 shares, a growth of 13.8% from the December 31st total of 6,500 shares. Based on an average trading volume of 11,800 shares, the days-to-cover ratio is currently 0.6 days.

Tema Oncology ETF Stock Down 0.8 %

Shares of Tema Oncology ETF stock opened at $25.69 on Monday. The stock’s fifty day moving average is $25.56 and its two-hundred day moving average is $27.44. The company has a market capitalization of $65.51 million, a PE ratio of 26.86 and a beta of 1.11. Tema Oncology ETF has a 52 week low of $23.97 and a 52 week high of $30.11.

Tema Oncology ETF Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Thursday, December 12th. Shareholders of record on Wednesday, December 11th were given a $0.7283 dividend. The ex-dividend date was Wednesday, December 11th.

Hedge Funds Weigh In On Tema Oncology ETF

An institutional investor recently raised its position in Tema Oncology ETF stock. Thrivent Financial for Lutherans lifted its position in shares of Tema Oncology ETF (NASDAQ:CANC – Free Report) by 25.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 399,509 shares of the company’s stock after buying an additional 80,133 shares during the quarter. Thrivent Financial for Lutherans owned approximately 22.96% of Tema Oncology ETF worth $11,351,000 at the end of the most recent quarter.

Tema Oncology ETF Company Profile

(Get Free Report)

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.